Diagnostic Imaging Centers Market By Type (Computer Tomography (CT-Scan) Centers, Medical Radiological Laboratories, Dental or Medical X-ray Laboratories, Ultrasound Imaging Centers, Magnetic Resonance Imaging (MRI) Centers); By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others); By End Use (Hospitals, Diagnostics Imaging Centers, Others); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
The Diagnostic Imaging Centers Market was valued at USD 535,023 million in 2024 and is anticipated to reach USD 822,962.1 million by 2032, at a CAGR of 5.53% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Diagnostic Imaging Centers Market Size 2024
USD 535,023 million
Diagnostic Imaging Centers Market, CAGR
5.53%
Diagnostic Imaging Centers Market Size 2032
USD 822,962.1 million
The is led by key players such as Siemens Healthineers, General Electric Company, Fujifilm Holdings Corporation, Samsung Medison Co. Ltd., and Hologic Inc. These companies dominate through advanced imaging technologies, broad product portfolios, and strong service networks. SimonMed/Dignity Health and Medical Imaging Corp. strengthen competition with expanding outpatient imaging centers across urban regions. Carestream Health Inc., Hitachi Medical Corporation, and Shimadzu Corporation contribute to innovation in digital radiology and ultrasound. North America holds the leading regional position, accounting for 38% of the global market share in 2024. The region’s dominance stems from widespread chronic disease prevalence, high diagnostic imaging adoption, and strong reimbursement frameworks.
Diagnostic Imaging Centers Market Insights
The Diagnostic Imaging Centers market was valued at USD 535,023 million in 2024 and is projected to reach USD 822,962.1 million by 2032, growing at a CAGR of 5.53%.
Rising chronic diseases, an aging population, and demand for early diagnosis are major drivers fueling imaging service utilization.
AI integration in MRI and CT systems, along with the growth of teleradiology, is reshaping diagnostic imaging workflows and expanding access.
Key players include Siemens Healthineers, GE Healthcare, Fujifilm, Samsung Medison, and Hologic, who compete on innovation, accuracy, and patient-centered services.
North America led the market with 38% share, followed by Europe at 26% and Asia Pacific at 21%. By type, MRI centers held the dominant share due to broad applications in neurology and oncology. Hospitals led the end-use segment due to advanced infrastructure and high patient volumes.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Magnetic Resonance Imaging (MRI) Centers held the largest market share in 2024 among all type segments. MRI centers are preferred due to their ability to provide high-resolution imaging for soft tissues, brain, and spinal cord diagnostics without radiation exposure. Growing use in neurology, orthopedics, and oncology strengthens their dominance. Rising chronic disease cases and aging populations further push demand for precise diagnosis. Advanced MRI units with faster scan times and 3D capabilities enhance throughput and patient comfort, encouraging adoption in both urban hospitals and standalone facilities.
For instance, Siemens Healthineers maintains an installed base of over 25,000 MAGNETOM MRI systems worldwide as of 2024–2025. The company’s MAGNETOM Free.Max system utilizes Deep Resolve AI-based image reconstruction to reduce scan times by up to 50% per sequence, while its myExam Companion automation supports higher patient volumes and simplified workflows in standalone MRI centers.
By Application
Oncology emerged as the leading application segment, accounting for the highest share in 2024. Cancer diagnostics require repeated and high-precision imaging, driving reliance on MRI, CT scans, and PET modalities. The rising global cancer burden, especially breast, lung, and colorectal cancers, fuels imaging demand. Early detection protocols and follow-up assessments further expand utilization. Government-led screening programs and increasing access to private cancer care centers contribute to segment growth. Integration of AI in oncology imaging also aids faster diagnosis and personalized treatment planning.
For instance, GE HealthCare uses AI-enabled oncology imaging software that is deployed globally across thousands of hospitals. Its Edison platform is designed to integrate large-scale data and apply advanced analytics to generate insights, which helps to improve lesion detection (with tools like Precision DL) and increase workflow speed for cancer care providers.
By End Use
Hospitals dominated the end-use segment with the highest market share in 2024. Their access to comprehensive diagnostic infrastructure, skilled radiologists, and advanced imaging equipment makes them the preferred choice for complex cases. Hospitals also handle high patient volumes, including emergency and critical care imaging. Strategic investments in imaging suites within multi-specialty and tertiary hospitals drive adoption. Integration with electronic health records (EHRs) and centralized reporting systems enhances workflow efficiency. Expansion of public hospital infrastructure in emerging economies supports further market penetration.
Rising Chronic Disease Prevalence and Aging Population
The rising burden of chronic diseases significantly drives demand for diagnostic imaging services. Conditions such as cardiovascular disorders, cancer, diabetes, and neurological issues require regular imaging for diagnosis, treatment planning, and monitoring. An aging global population adds to the need for frequent diagnostic evaluations, particularly for osteoporosis, stroke, and age-related degenerative conditions. According to WHO, non-communicable diseases account for over 70% of global deaths, emphasizing the need for scalable diagnostic capacity. Imaging centers offer rapid, non-invasive evaluation tools that help physicians detect diseases early and manage them more effectively. As life expectancy increases, the dependency on advanced imaging techniques continues to grow. This demographic shift not only boosts imaging procedure volumes but also encourages investment in modern imaging infrastructure by hospitals and private providers.
For instance, Philips Healthcare reported that its products and solutions improved the lives of approximately 1.96 billion people in 2024, with a goal of reaching 2.5 billion lives annually by 2030.
Technological Advancements in Imaging Modalities
Innovations in imaging technologies significantly enhance diagnostic accuracy, speed, and patient safety. High-resolution imaging systems, 3D/4D ultrasound, digital X-ray, and AI-enabled MRI and CT scanners enable faster detection of abnormalities while reducing scan times. The integration of artificial intelligence and machine learning supports automated image analysis, tumor detection, and workflow optimization. These advancements reduce reporting time and improve diagnostic confidence. Portable and point-of-care imaging units expand access in remote and emergency settings. For instance, low-dose CT and silent MRI improve patient comfort and safety. Such innovations attract hospitals and diagnostic centers aiming to differentiate their service offerings. As demand rises for minimally invasive and early diagnostic tools, adoption of next-gen imaging systems accelerates, driving market growth. Equipment leasing options and vendor-financed solutions also make high-end imaging technology accessible to mid-size centers.
For instance, by 2025, Canon Medical Systems has surpassed a global footprint of over 18,000 Aquilion series CT systems. Its flagship Aquilion ONE platform supports whole-organ imaging in a single rotation by utilizing a 320-row detector that captures 16 centimeters of anatomical coverage.
Growing Demand for Preventive and Personalized Healthcare
A global shift toward preventive healthcare is pushing demand for early-stage diagnostics and routine health screening. Imaging centers benefit from this trend as advanced modalities detect subtle anatomical and physiological changes before symptoms arise. Preventive screening programs for breast cancer (mammography), cardiovascular disease (cardiac CT), and lung cancer (low-dose CT) are becoming standard practice across developed and emerging nations. Personalized medicine also demands precise imaging insights to tailor therapies based on individual anatomy or tumor characteristics. Diagnostic imaging plays a central role in tracking treatment efficacy and adjusting regimens in real time. This trend aligns with value-based care models, where improved patient outcomes are prioritized over procedure volumes. As governments, employers, and insurers invest more in wellness and screening, imaging centers are well-positioned to capture growing preventive care demand.
Integration of Artificial Intelligence in Diagnostic Imaging
Artificial intelligence (AI) is reshaping the diagnostic imaging landscape by streamlining interpretation and enhancing clinical accuracy. AI-powered algorithms assist in rapid image segmentation, anomaly detection, and prioritization of critical cases, reducing radiologist workload. Solutions like computer-aided detection (CAD) are now integrated across MRI, CT, and mammography systems. AI also aids in reconstructing sharper images from fewer scans, lowering radiation exposure. Cloud-based PACS (Picture Archiving and Communication Systems) combined with AI analytics support remote diagnostics and second opinions. The increasing availability of FDA-cleared AI tools encourages adoption across small and mid-sized imaging centers. As reimbursement models begin to recognize AI-supported workflows, this trend opens up new revenue channels for vendors. It also creates a competitive edge for early adopters offering faster, more accurate imaging services.
For instance, Aidoc had its FDA-cleared AI solutions deployed in over 1,200 hospitals by 2024. The platform analyzed more than 30 million medical imaging scans annually, flagging critical findings such as intracranial hemorrhage and pulmonary embolism within minutes.
Expansion of Teleradiology and Remote Diagnostics
Teleradiology is emerging as a crucial enabler in extending imaging services beyond urban areas. It allows diagnostic imaging centers to transmit medical images to offsite radiologists for interpretation, overcoming the shortage of specialized professionals in rural or underserved regions. The growing availability of high-speed internet and secure cloud platforms facilitates real-time collaboration between imaging technicians and remote experts. This model is especially beneficial during emergencies, night shifts, or in facilities with low patient volumes. Global outsourcing of radiology services is also increasing due to cost-effectiveness and time-zone advantages. Diagnostic imaging centers adopting teleradiology gain scalability, wider coverage, and better turnaround times. It creates opportunities to tap new markets and optimize radiologist resources. Regulatory support and advances in cybersecurity further strengthen the potential of this trend.
Diagnostic Imaging Centers Market Key Challenges
High Capital and Operational Costs
Establishing and operating diagnostic imaging centers requires significant financial investment. High-end imaging equipment such as MRI, PET-CT, and digital radiography units involve large upfront capital costs. Ongoing expenses include equipment maintenance, calibration, licensing fees, and compliance with safety and radiation standards. Trained staff, including radiologists, technicians, and IT professionals, further increase the cost burden. Smaller clinics and centers often struggle to match the technological capabilities of larger hospitals due to budget constraints. In price-sensitive markets, cost recovery from each scan is low, extending the break-even period. Additionally, reimbursement delays or low insurance coverage for advanced imaging reduce profitability. These challenges limit market entry and expansion, especially for standalone and independent imaging providers.
Regulatory Compliance and Data Security Concerns
Diagnostic imaging centers must navigate complex regulatory environments related to radiation safety, data privacy, and equipment certification. Compliance with guidelines from authorities such as the FDA, AERB, HIPAA, and other local health departments is mandatory but resource-intensive. Any deviation can lead to penalties, suspension, or loss of accreditation. With increasing digitization, medical image storage and sharing raise cybersecurity concerns. Breaches of patient health data can damage a center’s reputation and result in legal consequences. Maintaining secure PACS and protecting systems from ransomware or unauthorized access require continuous IT upgrades. For smaller providers, implementing robust cybersecurity and compliance frameworks remains a persistent challenge, limiting their ability to scale operations digitally.
North America accounted for the largest share of the Diagnostic Imaging Centers market in 2024, holding approximately 38% of global revenue. The region benefits from advanced healthcare infrastructure, strong reimbursement frameworks, and high diagnostic imaging adoption. The U.S. leads the region due to its high chronic disease burden, rapid technology uptake, and growing preference for preventive care. Presence of leading imaging equipment manufacturers and AI integration further accelerates market growth. Canada also contributes with expanding public-private diagnostic partnerships. Continued investments in outpatient imaging centers and demand for low-radiation modalities support sustained regional dominance through 2032.
Europe
Europe held around 26% share of the global market in 2024, driven by robust healthcare systems, favorable screening programs, and an aging population. Germany, the UK, and France lead due to widespread use of CT, MRI, and ultrasound imaging in chronic care management. EU regulations mandate high imaging standards, supporting quality investments in digital radiology. The region’s focus on early cancer detection and cross-border health services also drives imaging volumes. Public-private collaborations and AI-enhanced teleradiology services expand rural reach. Europe’s steady adoption of digital workflows positions it for moderate yet consistent growth.
Asia Pacific
Asia Pacific emerged as the fastest-growing region, with a market share of 21% in 2024, projected to rise steadily through 2032. Rapid urbanization, expanding middle-class populations, and increased healthcare spending fuel demand across India, China, and Southeast Asia. Governments invest heavily in diagnostics infrastructure to improve rural access and early disease detection. Private imaging chains expand aggressively in metro and tier-2 cities. China leads in imaging unit deployment, while India sees rising demand for ultrasound and X-ray modalities. Local manufacturing and AI partnerships support affordable imaging solutions, making Asia Pacific a key growth hub.
Latin America
Latin America captured about 8% of the global Diagnostic Imaging Centers market in 2024. Brazil and Mexico are the primary contributors due to improving healthcare access and increasing chronic disease prevalence. The region benefits from public diagnostic screening campaigns, especially for cancer and maternal health. However, high equipment costs and limited reimbursement policies restrict wider access to advanced imaging like MRI and CT in rural zones. Private diagnostic chains continue to grow in urban areas, supported by regional partnerships and portable imaging solutions. Market growth remains steady, driven by rising awareness and improved insurance coverage.
Middle East & Africa
The Middle East & Africa region held a 7% market share in 2024, with potential for growth in select economies. Gulf nations such as the UAE and Saudi Arabia invest in advanced diagnostic infrastructure as part of healthcare transformation plans. These countries offer high adoption of MRI and CT technologies, supported by international hospital collaborations. In contrast, sub-Saharan Africa faces limited access due to cost and workforce shortages. Growth is primarily driven by mobile imaging units and government-led screening initiatives. Efforts to boost medical tourism and digital imaging will support gradual expansion across the region.
Diagnostic Imaging Centers Market Segmentations:
By Type:
Computer Tomography (CT-Scan) Centers
Medical Radiological Laboratories
Dental or Medical X-ray Laboratories
Ultrasound Imaging Centers
Magnetic Resonance Imaging (MRI) Centers
By Application:
Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Others
By End Use:
Hospitals
Diagnostics Imaging Centers
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The Diagnostic Imaging Centers market features a mix of multinational corporations, regional providers, and specialized imaging service networks. Key players such as Siemens Healthineers, General Electric Company, Fujifilm Holdings Corporation, and Samsung Medison Co. Ltd. dominate through their integrated imaging equipment and diagnostics service portfolios. These companies maintain a competitive edge through continuous innovation in AI-powered imaging, radiation dose reduction, and 3D imaging technologies. Service providers like SimonMed/Dignity Health and Medical Imaging Corp. expand their presence through strategic acquisitions and outpatient center growth. Carestream Health, Hitachi Medical Corporation, and Hologic Inc. focus on modality-specific excellence, especially in women’s health and portable imaging. The market is highly competitive, with pricing pressure in emerging regions and strong brand loyalty in developed markets. Partnerships with hospitals, equipment leasing models, and turnkey imaging solutions further shape competition. Vendors invest heavily in digital platforms, teleradiology integration, and patient-centric services to retain and expand their customer base.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In March 2025, Bunkerhill Health and Cleerly partnered to advance noninvasive cardiovascular care using AI-powered coronary CT angiography.
In January 2025, Sutter Health signed a seven-year strategic imaging partnership with GE HealthCare covering PET/CT, SPECT/CT, MRI, CT, X-ray, and ultrasound platforms.
In November 2024, GE HealthCare and RadNet collaborated to integrate SmartMammo AI into GE’s Senographe Pristina mammography system.
Report Coverage
The research report offers an in-depth analysis based on Type, Application, End-Use and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for advanced imaging centers will grow with the rising focus on early disease detection.
AI-powered diagnostic tools will enhance image interpretation speed and accuracy.
Outpatient imaging centers will expand rapidly in urban and semi-urban regions.
Portable and point-of-care imaging devices will see higher adoption in rural areas.
Integration of imaging systems with electronic health records will improve clinical workflows.
Teleradiology services will expand to bridge the gap in radiologist availability.
Low-dose and non-invasive imaging technologies will gain preference among patients and clinicians.
Investment in specialized imaging for oncology, cardiology, and neurology will increase.
Regulatory focus on safety, privacy, and quality assurance will shape service models.
Strategic collaborations between hospitals, diagnostic firms, and tech providers will drive innovation.
9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
13. Price Analysis
14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Carestream Health Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Fujifilm Holdings Corporation
14.3.3. General Electric Company
14.3.4. Hitachi Medical Corporation
14.3.5. Hologic Inc.
14.3.6. Medical Imaging Corp.
14.3.7. Samsung Medison Co. Ltd.
14.3.8. Shimadzu Corporation
14.3.9. Siemens
14.3.10. SimonMed/Dignity Health
15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for the Diagnostic Imaging Centers market, and what is its projected size in 2032?
The market was valued at USD 535,023 million in 2024 and is projected to reach USD 822,962.1 million by 2032.
At what Compound Annual Growth Rate is the Diagnostic Imaging Centers market projected to grow between 2024 and 2032?
The market is expected to grow at a CAGR of 5.53% during the forecast period.
Which Diagnostic Imaging Centers market segment held the largest share in 2024?
Magnetic Resonance Imaging (MRI) Centers held the largest share due to high demand for advanced, radiation-free diagnostics.
What are the primary factors fueling the growth of the Diagnostic Imaging Centers market?
The Vietnam Oral Solid Dosage Contract Manufacturing Market size was valued at USD 98 million in 2024 and is anticipated to reach USD 162.17 million by 2032, growing at a CAGR of 6.48% during the forecast period.
The Vietnam Eye Care Market size was valued at USD 29 million in 2024 and is anticipated to reach USD 42.22 million by 2032, growing at a CAGR of 5.03% during the forecast period.
The Veterinary Regenerative Medicine Market size was valued at USD 325 million in 2024 and is anticipated to reach USD 847.33 million by 2032, growing at a CAGR of 12.74% during the forecast period.
The US Dental Care Market size was valued at USD 166,095 million in 2024 and is anticipated to reach USD 247,273.6 million by 2032, growing at a CAGR of 5.1% during the forecast period.
The Urothelial Cancer Treatment Market size was valued at USD 2,887 million in 2024 and is anticipated to reach USD 13,531.47 million by 2032, at a CAGR of 21.3% during the forecast period.
The Manual Resuscitator Market size was valued at USD 640.4 million in 2024 and is anticipated to reach USD 1,036.2 million by 2032, growing at a CAGR of 6.2% during the forecast period.
The Airway Stent / Lung Stent Market is projected to grow from USD 91.45 million in 2025 to an estimated USD 151.82 million by 2032, with a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.
Liposuction market size was valued at USD 1,893 million in 2024 and is anticipated to reach USD 4,590.3 million by 2032, growing at a CAGR of 11.71% during the forecast period.
The IV Infusion Pump Accessories Market size was valued at USD 2,680 million in 2024 and is anticipated to reach USD 3,695.8 million by 2032, at a CAGR of 4.1% during the forecast period.
Insomnia Treatment Market size was valued at USD 3,497 million in 2024 and is anticipated to reach USD 5,135.88 million by 2032, at a CAGR of 4.92% during the forecast period.
The Irritable Bowel Syndrome with Constipation Drugs Market size was valued at USD 4,130 million in 2024 and is anticipated to reach USD 7,814.93 million by 2032, growing at a CAGR of 8.3% during the forecast period.
The AI in Clinical Trials Market is projected to grow from USD 2,538.43 million in 2025 to an estimated USD 12,240.4 million by 2032, registering a CAGR of 25.20% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
